A new study has found that the two major types of signalling pathways activated during brain cell development-the epidermal growth factor receptor pathway and the Notch pathway-operate together to determine how many and which types of brain cells are created during growth and repair in developing and adult brains.
The finding by researchers at the Center for Neuroscience Research at Children's National Medical Center, could aid in designing new ways to induce the brain to repair itself when these signals are interrupted.
The knowledge also indicates a need for further research to determine whether disruptions of these pathways in early brain development could lead to common neurodevelopmental disorders such as epilepsy, cerebral palsy, autism, Down syndrome, ADHD, and intellectual disabilities.
"These signaling pathways, normally activated during brain development, work in concert through the cellular microenvironment and through interactions with existing brain cells to determine how many of each type of brain cell are required for proper brain function," she added.
The researchers opted for an approach in a laboratory setting that modified genes involved in the two signaling pathways.
The approach induced gain or loss of function, allowing researchers to change the properties of neural stem cells as they developed-including altering the size of the pool of neural stem cells in the brain, the number of viable neural stem cells, and types of brain cells these stem cells ultimately become.
Neural stem cells can develop into all major cell types of the brain.
The discovery of the interaction between the two types of cellular signaling pathways is a critical step toward understanding, and potentially impacting, the molecular networks that regulate the cellular microenvironments, or niches, in which these neural stem cells operate.
"Children's National provides an ideal setting for pursuing this research, because we are able to use a multidisciplinary approach to our studies," said Gallo.
"Investigators and clinical fellows work together in the labs to tackle important questions that have great clinical importance for children with neurodevelopmental disabilities, and tap resources and expertise at other institutions as well. This environment allows us to translate our findings into the design of specific therapeutic approaches, working together with neuroscientists, child neurologists, neurosurgeons, and neuro-oncologists," he added.
These findings are published in the latest issue of Nature.